Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Bulletin Du Cancer|December 11, 2019
[Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Mathieu Puyade, Céline Labeyrie, Manuela Badoglio, et al.Bulletin Du Cancer|July 17, 2021
[Autologous hematopoietic cells for severe autoimmune diseases: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) for immune monitoring and biobanking]Pauline Lansiaux, Séverine Loisel, Cristina Castilla-Llorente, et al.Frontiers in Neurology|December 28, 2020
Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)Fiona Roberts, Helen Hobbs, Helen Jessop, et al.Bulletin Du Cancer|October 17, 2020
[Crohn's disease and autologous hemapoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Mathieu Puyade, Xavier Treton, Laurent Alric, et al.Bulletin Du Cancer|November 28, 2017
[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Grégory Pugnet, Christina Castilla-Llorente, Mathieu Puyade, et al.Rheumatology (Oxford, England)|April 9, 2021
Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory studyMatthias Papo, Chloé Friedrich, Laure Delaval, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2021
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or OlderLucie Oberic, Frederic Peyrade, Mathieu Puyade, et al.Journal for Immunotherapy of Cancer|May 31, 2023
Prognosis of immune checkpoint inhibitors-induced myocarditis: a case seriesCyrille Coustal, Juliette Vanoverschelde, Xavier Quantin, et al.Bulletin Du Cancer|September 6, 2024
[Prerequisite and organisation of health-care pathways for Cell and Gene therapies, using Mesenchymal Stromal Cells (MSC) or Chimeric Antigen Receptor (CAR) T cells, in patients with autoimmune systemic diseases]Christina Castilla-Llorente, Agnès Bonnin, Pauline Lansiaux, et al.Bone Marrow Transplantation|August 19, 2025
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeTobias Alexander, Elisa Roldan, Nicoletta Del Papa, et al.Pageof 5